Locations:
Search
Optimized models can personalize predictions for patients with prostate, breast and other cancers
A new study indicates that the combined approaches can be performed without mortality and with acceptable morbidity
Treatment addresses endocrine resistance
Patient able to avoid surgery and radiation despite having rapidly growing mass
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Leukocoria is the most common symptom of this rare childhood eye cancer
The retrospective study also identified predictors for which patients would likely achieve a complete response from TNT
Previous studies, trial aims and the potential role of immunotherapy
FDA-approved therapy offers promise for patients with castrate-resistant prostate cancer
Using novel robotic approaches for a difficult-to-access prostate
Helping patients with cancer struggling with depression, anxiety and other mental health issues
Advertisement
Advertisement